Company / Current Assets per Share
Adaptimmune Therapeutics PLC Current Assets per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.14
FY2024
5-year range
$0.14 / $0.63
FY2020-FY2024
Trend
-34.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 4 consecutive years, from $0.63 in FY2020 to $0.14 in FY2024.
Based on SEC 10-K filings.
0.14 in FY2024 with a 5-year CAGR of -6.4%.
Declined from $0.28 to $0.14 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -32.4%
- 5-Year CAGR
- -6.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Adaptimmune Therapeutics PLC's current assets per share has declined for 4 consecutive years.
- In FY2024, current assets per share decreased 34.3% year-over-year.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.14 | -34.3% |
| FY2023 | $0.21 | -23.5% |
| FY2022 | $0.28 | -38.5% |
| FY2021 | $0.45 | -29.1% |
| FY2020 | $0.63 | +228.6% |
| FY2019 | $0.19 | -53.3% |
| FY2018 | $0.41 | -24.1% |
| FY2017 | $0.54 | +15.8% |
| FY2016 | $0.47 | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026